最新指南丨ACR&EULAR联合发布肉芽肿性多血管炎、显微镜下多血管炎和嗜酸性肉芽肿性对血管炎新分类标准

2022-04-18 木木 MedSci原创

由ACR和EULAR联合发布的2022年血管炎分类标准已经陆续发布在风湿领域权威期刊发布。

由ACR和EULAR联合发布的2022年血管炎分类标准已经陆续发布在风湿领域权威期刊Arthritis & RheumatologyAnnals of Rheumatic Diseases杂志上。本文梳理目前已经发布的各血管炎诊断标准,关注本公众号,外刊同步更新。

 

1

嗜酸性肉芽肿性多血管炎

图片

 

EGPA 分类标准的制定中纳入了107例EGPA和450个对照。验证集由另外119例EGPA和437例比较器组成。通过回归分析从91个候选项目中确定了11个EPGA 项目,最终确定7个项目。

 

图片

DOI: 10.1136/annrheumdis-2021-221794

 

2

肉芽肿性多血管炎

图片

 

肉芽肿性多血管炎(GPA)分类标准的制定中纳入了578个GPA案例和652个比较器组成。验证集由另外146个GPA病例和161个对照组成。回归分析从91个候选项目中确定了GPA的26个项目,最终确定10个项目。

 

图片

 

图片

 

  • DOI: 10.1002 / art.41986

 

 

3

显微镜下多血管炎

图片

显微镜下多血管炎(MPA)的分类标准的制定中纳入了149例MPA和408个对照组。验证集由另外142例MPA和414例对照组成。从91个候选项目中,回归分析确定了10个MPA项目,最终确定6条项目。

 

图片

 

该标准敏感性91%、特异性94%。

 

图片

  • DOI: 10.1136/annrheumdis-2021-221796

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1744035, encodeId=7acd1e4403516, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Thu Feb 23 11:44:17 CST 2023, time=2023-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923387, encodeId=68d5192338edc, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Sat Jun 11 21:44:17 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736381, encodeId=fdbd1e3638130, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Sun Jun 19 06:44:17 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235624, encodeId=8e0c12356247c, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69838227617, createdName=ms1000001450938416, createdTime=Sat Jul 30 12:22:40 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022343, encodeId=755520223431c, content=<a href='/topic/show?id=6d35402485d' target=_blank style='color:#2F92EE;'>#嗜酸性肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40248, encryptionId=6d35402485d, topicName=嗜酸性肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Sat Oct 15 12:44:17 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263276, encodeId=849b12632e6ec, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344802, encodeId=b7fb1344802ac, content=<a href='/topic/show?id=0e98808e9f9' target=_blank style='color:#2F92EE;'>#肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80879, encryptionId=0e98808e9f9, topicName=肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a12500213, createdName=12498f1em08(暂无昵称), createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400544, encodeId=247414005445b, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422981, encodeId=171c14229818c, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455370, encodeId=c1cc14553e0ad, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1744035, encodeId=7acd1e4403516, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Thu Feb 23 11:44:17 CST 2023, time=2023-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923387, encodeId=68d5192338edc, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Sat Jun 11 21:44:17 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736381, encodeId=fdbd1e3638130, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Sun Jun 19 06:44:17 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235624, encodeId=8e0c12356247c, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69838227617, createdName=ms1000001450938416, createdTime=Sat Jul 30 12:22:40 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022343, encodeId=755520223431c, content=<a href='/topic/show?id=6d35402485d' target=_blank style='color:#2F92EE;'>#嗜酸性肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40248, encryptionId=6d35402485d, topicName=嗜酸性肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Sat Oct 15 12:44:17 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263276, encodeId=849b12632e6ec, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344802, encodeId=b7fb1344802ac, content=<a href='/topic/show?id=0e98808e9f9' target=_blank style='color:#2F92EE;'>#肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80879, encryptionId=0e98808e9f9, topicName=肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a12500213, createdName=12498f1em08(暂无昵称), createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400544, encodeId=247414005445b, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422981, encodeId=171c14229818c, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455370, encodeId=c1cc14553e0ad, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1744035, encodeId=7acd1e4403516, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Thu Feb 23 11:44:17 CST 2023, time=2023-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923387, encodeId=68d5192338edc, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Sat Jun 11 21:44:17 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736381, encodeId=fdbd1e3638130, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Sun Jun 19 06:44:17 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235624, encodeId=8e0c12356247c, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69838227617, createdName=ms1000001450938416, createdTime=Sat Jul 30 12:22:40 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022343, encodeId=755520223431c, content=<a href='/topic/show?id=6d35402485d' target=_blank style='color:#2F92EE;'>#嗜酸性肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40248, encryptionId=6d35402485d, topicName=嗜酸性肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Sat Oct 15 12:44:17 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263276, encodeId=849b12632e6ec, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344802, encodeId=b7fb1344802ac, content=<a href='/topic/show?id=0e98808e9f9' target=_blank style='color:#2F92EE;'>#肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80879, encryptionId=0e98808e9f9, topicName=肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a12500213, createdName=12498f1em08(暂无昵称), createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400544, encodeId=247414005445b, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422981, encodeId=171c14229818c, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455370, encodeId=c1cc14553e0ad, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=)]
    2022-06-19 贵阳
  4. [GetPortalCommentsPageByObjectIdResponse(id=1744035, encodeId=7acd1e4403516, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Thu Feb 23 11:44:17 CST 2023, time=2023-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923387, encodeId=68d5192338edc, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Sat Jun 11 21:44:17 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736381, encodeId=fdbd1e3638130, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Sun Jun 19 06:44:17 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235624, encodeId=8e0c12356247c, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69838227617, createdName=ms1000001450938416, createdTime=Sat Jul 30 12:22:40 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022343, encodeId=755520223431c, content=<a href='/topic/show?id=6d35402485d' target=_blank style='color:#2F92EE;'>#嗜酸性肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40248, encryptionId=6d35402485d, topicName=嗜酸性肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Sat Oct 15 12:44:17 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263276, encodeId=849b12632e6ec, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344802, encodeId=b7fb1344802ac, content=<a href='/topic/show?id=0e98808e9f9' target=_blank style='color:#2F92EE;'>#肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80879, encryptionId=0e98808e9f9, topicName=肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a12500213, createdName=12498f1em08(暂无昵称), createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400544, encodeId=247414005445b, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422981, encodeId=171c14229818c, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455370, encodeId=c1cc14553e0ad, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=)]
    2022-07-30 ms1000001450938416

    感谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1744035, encodeId=7acd1e4403516, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Thu Feb 23 11:44:17 CST 2023, time=2023-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923387, encodeId=68d5192338edc, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Sat Jun 11 21:44:17 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736381, encodeId=fdbd1e3638130, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Sun Jun 19 06:44:17 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235624, encodeId=8e0c12356247c, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69838227617, createdName=ms1000001450938416, createdTime=Sat Jul 30 12:22:40 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022343, encodeId=755520223431c, content=<a href='/topic/show?id=6d35402485d' target=_blank style='color:#2F92EE;'>#嗜酸性肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40248, encryptionId=6d35402485d, topicName=嗜酸性肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Sat Oct 15 12:44:17 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263276, encodeId=849b12632e6ec, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344802, encodeId=b7fb1344802ac, content=<a href='/topic/show?id=0e98808e9f9' target=_blank style='color:#2F92EE;'>#肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80879, encryptionId=0e98808e9f9, topicName=肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a12500213, createdName=12498f1em08(暂无昵称), createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400544, encodeId=247414005445b, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422981, encodeId=171c14229818c, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455370, encodeId=c1cc14553e0ad, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1744035, encodeId=7acd1e4403516, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Thu Feb 23 11:44:17 CST 2023, time=2023-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923387, encodeId=68d5192338edc, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Sat Jun 11 21:44:17 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736381, encodeId=fdbd1e3638130, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Sun Jun 19 06:44:17 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235624, encodeId=8e0c12356247c, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69838227617, createdName=ms1000001450938416, createdTime=Sat Jul 30 12:22:40 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022343, encodeId=755520223431c, content=<a href='/topic/show?id=6d35402485d' target=_blank style='color:#2F92EE;'>#嗜酸性肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40248, encryptionId=6d35402485d, topicName=嗜酸性肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Sat Oct 15 12:44:17 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263276, encodeId=849b12632e6ec, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344802, encodeId=b7fb1344802ac, content=<a href='/topic/show?id=0e98808e9f9' target=_blank style='color:#2F92EE;'>#肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80879, encryptionId=0e98808e9f9, topicName=肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a12500213, createdName=12498f1em08(暂无昵称), createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400544, encodeId=247414005445b, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422981, encodeId=171c14229818c, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455370, encodeId=c1cc14553e0ad, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1744035, encodeId=7acd1e4403516, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Thu Feb 23 11:44:17 CST 2023, time=2023-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923387, encodeId=68d5192338edc, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Sat Jun 11 21:44:17 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736381, encodeId=fdbd1e3638130, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Sun Jun 19 06:44:17 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235624, encodeId=8e0c12356247c, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69838227617, createdName=ms1000001450938416, createdTime=Sat Jul 30 12:22:40 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022343, encodeId=755520223431c, content=<a href='/topic/show?id=6d35402485d' target=_blank style='color:#2F92EE;'>#嗜酸性肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40248, encryptionId=6d35402485d, topicName=嗜酸性肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Sat Oct 15 12:44:17 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263276, encodeId=849b12632e6ec, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344802, encodeId=b7fb1344802ac, content=<a href='/topic/show?id=0e98808e9f9' target=_blank style='color:#2F92EE;'>#肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80879, encryptionId=0e98808e9f9, topicName=肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a12500213, createdName=12498f1em08(暂无昵称), createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400544, encodeId=247414005445b, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422981, encodeId=171c14229818c, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455370, encodeId=c1cc14553e0ad, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1744035, encodeId=7acd1e4403516, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Thu Feb 23 11:44:17 CST 2023, time=2023-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923387, encodeId=68d5192338edc, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Sat Jun 11 21:44:17 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736381, encodeId=fdbd1e3638130, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Sun Jun 19 06:44:17 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235624, encodeId=8e0c12356247c, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69838227617, createdName=ms1000001450938416, createdTime=Sat Jul 30 12:22:40 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022343, encodeId=755520223431c, content=<a href='/topic/show?id=6d35402485d' target=_blank style='color:#2F92EE;'>#嗜酸性肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40248, encryptionId=6d35402485d, topicName=嗜酸性肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Sat Oct 15 12:44:17 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263276, encodeId=849b12632e6ec, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344802, encodeId=b7fb1344802ac, content=<a href='/topic/show?id=0e98808e9f9' target=_blank style='color:#2F92EE;'>#肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80879, encryptionId=0e98808e9f9, topicName=肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a12500213, createdName=12498f1em08(暂无昵称), createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400544, encodeId=247414005445b, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422981, encodeId=171c14229818c, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455370, encodeId=c1cc14553e0ad, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=)]
    2022-04-20 10518094zz
  9. [GetPortalCommentsPageByObjectIdResponse(id=1744035, encodeId=7acd1e4403516, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Thu Feb 23 11:44:17 CST 2023, time=2023-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923387, encodeId=68d5192338edc, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Sat Jun 11 21:44:17 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736381, encodeId=fdbd1e3638130, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Sun Jun 19 06:44:17 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235624, encodeId=8e0c12356247c, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69838227617, createdName=ms1000001450938416, createdTime=Sat Jul 30 12:22:40 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022343, encodeId=755520223431c, content=<a href='/topic/show?id=6d35402485d' target=_blank style='color:#2F92EE;'>#嗜酸性肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40248, encryptionId=6d35402485d, topicName=嗜酸性肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Sat Oct 15 12:44:17 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263276, encodeId=849b12632e6ec, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344802, encodeId=b7fb1344802ac, content=<a href='/topic/show?id=0e98808e9f9' target=_blank style='color:#2F92EE;'>#肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80879, encryptionId=0e98808e9f9, topicName=肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a12500213, createdName=12498f1em08(暂无昵称), createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400544, encodeId=247414005445b, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422981, encodeId=171c14229818c, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455370, encodeId=c1cc14553e0ad, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=)]
  10. [GetPortalCommentsPageByObjectIdResponse(id=1744035, encodeId=7acd1e4403516, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Thu Feb 23 11:44:17 CST 2023, time=2023-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1923387, encodeId=68d5192338edc, content=<a href='/topic/show?id=1408583e45d' target=_blank style='color:#2F92EE;'>#新指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58374, encryptionId=1408583e45d, topicName=新指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac782500066, createdName=12498768m13(暂无昵称), createdTime=Sat Jun 11 21:44:17 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1736381, encodeId=fdbd1e3638130, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Sun Jun 19 06:44:17 CST 2022, time=2022-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235624, encodeId=8e0c12356247c, content=感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69838227617, createdName=ms1000001450938416, createdTime=Sat Jul 30 12:22:40 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2022343, encodeId=755520223431c, content=<a href='/topic/show?id=6d35402485d' target=_blank style='color:#2F92EE;'>#嗜酸性肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40248, encryptionId=6d35402485d, topicName=嗜酸性肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a22500182, createdName=1696533704_45270454, createdTime=Sat Oct 15 12:44:17 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263276, encodeId=849b12632e6ec, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344802, encodeId=b7fb1344802ac, content=<a href='/topic/show?id=0e98808e9f9' target=_blank style='color:#2F92EE;'>#肉芽肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80879, encryptionId=0e98808e9f9, topicName=肉芽肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=09a12500213, createdName=12498f1em08(暂无昵称), createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400544, encodeId=247414005445b, content=<a href='/topic/show?id=e7c018e7af' target=_blank style='color:#2F92EE;'>#ACR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1877, encryptionId=e7c018e7af, topicName=ACR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19792261142, createdName=10518094zz, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422981, encodeId=171c14229818c, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455370, encodeId=c1cc14553e0ad, content=<a href='/topic/show?id=4272e0771a' target=_blank style='color:#2F92EE;'>#EULAR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7077, encryptionId=4272e0771a, topicName=EULAR)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f855654200, createdName=muzishouyi, createdTime=Wed Apr 20 04:44:17 CST 2022, time=2022-04-20, status=1, ipAttribution=)]
    2022-04-20 muzishouyi

相关资讯

ARD:独特的循环miRNA谱突出了Behçet综合征中的血栓炎症

循环microRNA (ci-miRNA)在可能代表一种新型的、侵袭性低的白塞综合征 (BS) 生物标志物,同时表明BS相关血栓炎症的表观遗传控制。 

Lancet Rheumatology: 原发性系统性血管炎或风湿性多肌痛患者COVID-19的结果:一项回顾性队列研究

在原发性系统性血管炎和风湿性多肌痛患者中,严重的COVID-19结局与年龄、性别、合并症数量以及治疗方法(包括大剂量糖皮质激素)等多个风险因素相关。

ARD:EULAR对风湿性和肌肉骨骼疾病(包括系统性红斑狼疮和抗磷脂综合征)心血管风险管理的建议

为痛风、血管炎、系统性硬化症 (SSc)、肌炎、混合性结缔组织病 (MCTD)、干燥综合征 (SS)、系统性红斑狼疮 (SLE) 和抗磷脂综合征 (APS) 的心血管风险(CVR) 管理制定建议。

警惕!类风湿不仅表现在关节内!竟会牵连皮肤,出现破溃

类风湿关节炎出现皮肤症状可能是合并血管炎在作祟。

新发现!新冠病毒也有皮肤病症!但更多的是欧美人群出现问题!

与新冠肺炎相关的皮肤表现机制尚不清楚,但已经提出了一些假设。目前尚不清楚皮肤症状是SARS-CoV-2感染、病毒后免疫反应的继发结果,还是皮肤本身的原发感染。

免费回看:ANCA相关血管炎的诊断与治疗新进展

北京协和医院 风湿免疫内科 李菁副教授